The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review. - Wikidata - wikimedia - TriplyDB

The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.

The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.

http://www.wikidata.org/entity/Q36940038

about

Topical tacrolimus for atopic dermatitis Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use.Tacrolimus ointment: a novel and effective topical treatment of localized atopic dermatitis in a rhesus macaque (Macaca mulatta).Novel topical therapies for distal colitis.Clinical pearls from atopic dermatitis and its infectious complications.Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs.Topical calcineurin inhibitors in systemic lupus erythematosus.The use of topical tacrolimus 0.1% skin ointment for anterior segment conditions: a case series.Tacrolimus ointment in the management of atopic dermatitis.Ocular surface squamous neoplasia in an immunosuppressed patient with atopic keratoconjunctivitis.Preparation and in vitro evaluation of tacrolimus-loaded ethosomes

P2860

Q24186624-2F5C1086-01B2-4AC9-88C9-CC36F72F6141 Q36042131-A787CCB0-4E22-414A-BD3A-7A6F785A2017 Q37327264-268DAE9D-0B9F-421E-8C80-AB311D57483C Q37499041-2E201C65-CDC8-4E0F-811F-4A9E141565B4 Q37876204-3F770576-1BEE-41F3-AE20-DF1FCAD256ED Q38203586-09351A3B-5FC2-4353-B42A-946771C5798C Q38266892-1D310EED-4C13-40A0-9998-CC3727D4891E Q40122276-27C9A492-768A-4F5C-9036-05A3098F9958 Q40940942-4EB6F286-56A6-4226-A628-D3F59BF7AF24 Q42081579-D960B343-916A-4457-A4ED-3B708F331024 Q53161911-FCD1CC21-D242-4F5F-8448-BC85D143403D Q58915104-571A4AC2-B725-45F4-BF2E-74A23E520527

P2860

The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.

http://www.wikidata.org/entity/Q36940038

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.

@en

type

label

The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.

@en

prefLabel

The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.

@en

P1433

Q36940038-C953C5E8-AC0A-4EC1-8785-1CF22E078334

P1476

Q36940038-A8565D1F-66D3-46B9-B534-1E94141233A9

P2093

Q36940038-6272170D-686E-4D81-9A52-B1CB47FC8166

P2860

Q36940038-09448881-2C9B-4CDD-B223-EA23E22D0AB5

Q36940038-0FFE398A-4107-41D4-9C63-A0F41D01841E

Q36940038-12A92CD7-1BE5-455A-B009-34B8BFE9978F

Q36940038-1580EECD-6C0F-44FA-AB63-FD19DF560EFA

Q36940038-1DAD74EE-5A4A-40C3-9D3B-84FFF8CA00F6

Q36940038-1DEE4EC5-17BA-41B2-B4F9-B91DFAE7CF57

Q36940038-27E91FDD-8D61-4259-AD44-D14818BAB391

Q36940038-2934F88F-9474-4254-86AA-E4025D979C26

Q36940038-2A2710FD-8D44-49E5-BC7A-64789263EAB4

Q36940038-2A642665-3457-4C60-9677-F4EB705803E9

P304

Q36940038-0A531671-CA48-4CA0-AE9C-E77C4D8E93AC

P31

Q36940038-C18D16FC-52D4-4341-822B-92915AD0546E

P356

Q36940038-BFB22E4E-81B4-418E-A4ED-8EB07B707340

P407

Q36940038-924501FD-0278-4198-B520-3E147D13A3DB

P433

Q36940038-0C76905A-A210-4000-A64E-CD555BE82B9F

P478

Q36940038-0F665684-502D-4033-B9BF-B24E2D99F2EB

P577

Q36940038-4F78AA4B-B314-4ACA-9124-35A887D7583D

P5875

Q36940038-9E6F632E-A00A-4351-8A16-3A6F692D35F8

P698

Q36940038-C9CCA5A4-A074-44A7-BA99-26244ED0A834

P921

Q36940038-FF849C7C-705D-4DB1-953C-C9009677A47A

P356

J.1365-2133.2007.08177.X

P1433

British Journal of Dermatology

P1476

The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.

@en

P2093

Rustin MH

http://www.w3.org/2001/XMLSchema#string

P2860

FK506 inhibition of histamine release and cytokine production by mast cells and basophils

Topical immunomodulatory agents and their targets in inflammatory skin diseases.

Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis.

Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis.

The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force.

The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis.

The role of topical calcineurin inhibitors in atopic dermatitis.

Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children.

The efficacy and safety of tacrolimus ointment: a clinical review.

Malignancy after transplantation.

P304

861-873

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2133.2007.08177.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

157

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5986956

http://www.w3.org/2001/XMLSchema#string

P698

17854353

http://www.w3.org/2001/XMLSchema#string

P921